Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
Hua-Chun WengXin-Yu LuYu-Peng XuYi-Hong WangDan WangYi-Ling FengZhang ChiXiao-Qing YanChao-Sheng LuHong-Wei WangPublished in: Molecular medicine (Cambridge, Mass.) (2021)
These findings indicated that rhFGF21 could be a promising pharmacological strategy for the treatment of salt-sensitive hypertension-induced nephropathy.